Company: PGEN
Filing Date: 2025-05-16
Form Type: DEF 14A
Source: 0001140361-25-019470
Chunk: 37

Company: PRECIGEN, INC.
Filing Date: 2025-05-16
Form: DEF 14A
Chunk 37
---
 Stock and exercise of the Warrants. It is possible, however, that merger and acquisition opportunities involving the issuance of shares of Common Stock will develop. It is also possible that an increase in the market price of the Common Stock, and conditions in capital markets in general, may make a stock dividend, a stock split, or a public or private offering of Common Stock desirable. As is the case with the shares of Common Stock that are currently authorized but unissued, if the Proposed Amendment is adopted by the shareholders, the additional authorized shares of Common Stock may be issued for such consideration, cash or otherwise, at such times and in such amounts as the Board may determine without further shareholder approval, except to the extent that shareholder approval is required by applicable laws, rules, or regulations. Future issuances of shares of Common Stock upon the conversion of the Series A Preferred Stock and the exercise of the Warrants, if any, may cause a significant reduction in the percentage interests of our current shareholders in voting power, any liquidation value, our book and market value, and in any future earnings. Further, the issuance or resale of Common Stock issued pursuant to the Series A Preferred Stock and Warrants could cause the market price of our Common Stock to decline. In addition to the foregoing, the increase in the number of issued shares of Common Stock in connection with the Private Placement may have an incidental anti-takeover effect in that additional shares could be used to dilute the stock ownership of parties seeking to obtain control of us. The increased number of issued shares could discourage the possibility of, or render more difficult, certain mergers, tender offers, proxy contests or other change of control or ownership transactions. Shareholders do not generally have any preemptive or other rights to subscribe for any shares of Common Stock that may in the future be issued by the Company. If we do not obtain approval for this proposal, under the terms of the Securities Purchase Agreement, we are obligated to continue to solicit the approval of our shareholders until we obtain approval for the authorization of the Maximum Number of Underlying Shares by calling a special meeting every 90 days following the date of the most recent such meeting. If our shareholders approve this proposal, the Proposed Amendment will become effective upon the filing of a Certificate of Amendment with the Secretary of State of Virginia, which is expected to be filed as soon as reasonably practicable after the Annual Meeting. Vote Required and Board Recommendation The affirmative vote of a majority of the votes cast on the matter is required for the approval of this item. As this proposal is